Nicotine therapeutic benefits: Difference between revisions

Jump to navigation Jump to search
Add Parkinson’s study
m (fixed bad link in cat section)
(Add Parkinson’s study)
Line 971: Line 971:
<br>
<br>


='''Parkinson Disease'''=  
='''Parkinson Disease'''=
 
=== 2023: [https://www.frontiersin.org/articles/10.3389/fnagi.2023.1223310/full Changes in smoking, alcohol consumption, and the risk of Parkinson’s diseasel] ===
 
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/36817162/ Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease.] ===
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/36817162/ Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease.] ===
* Nicotine (Nic) has previously been proven to reduce neurodegeneration in the models of Parkinson's disease (PD). The present study is intended to investigate the detailed mechanisms related to the potential neuroprotective effects of Nic in vivo.
* Nicotine (Nic) has previously been proven to reduce neurodegeneration in the models of Parkinson's disease (PD). The present study is intended to investigate the detailed mechanisms related to the potential neuroprotective effects of Nic in vivo.
Line 1,313: Line 1,316:
**Keywords
**Keywords
**Other
**Other
[[Category:Studies, Surveys, and Papers]]
[[index.php?title=Category:Studies, Surveys, and Papers]]
Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Navigation menu